Research Study

Multi-Country Prospective ObserVAtionaL, Cohort Study of Patients With Moderate to Severe Chronic PlaqUE Psoriasis (VALUE)
Principal Investigator 
Vincent C. Ho

Overview

Body Locations and Systems 
Psoriasis
ClinicalTrials.gov# 
NCT03982394
Status 
Recruiting
Study Start/End 
Feb 19, 2020 to Jun 30, 2025
Locations 
Vancouver General Hospital
Name/Title 
Sze Wai Ho, Research Coordinator
Phone 
604-875-5296
Email Address 
szewai.ho@ubc.ca
Purpose of Study 

The purpose of this study is to assess the use of risankizumab in adult patients with moderate to severe chronic plaque psoriasis and compare risankizumab to other commonly used biologics.

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.